List view / Grid view
In this issue: DNA microarray for detecting, identifying and determining antimicrobial-resistant bacteria; the advantages of single-use technology and a framework for an implementation strategy; risk management when designing chemical safety assessments for pharmaceutical packaging systems.
12 February 2018 | By Scott Rudge, COO, RMC Pharmaceutical Solutions Inc
Single-use systems have become an important tool in the development and scale up of biotechnology processes. Single-use systems save space, increase flexibility in scale and space planning and, to a large extent, eliminate cleaning costs in development and change over. However, single-use systems come with their own challenges, including complete…
Human brains have to manage an inconceivably massive amount of information. By current estimations, we are offloading, transferring, and storing information upward of 2.5 quintillion bytes a day...
The prevailing view would perhaps be that the industry is not good at innovation, because it is conservative and risk averse. BPOG Director Simon Chalk shares his own views.
By combining Patheon’s capabilities in drug development and manufacturing with its clinical trials packaging and logistics expertise, Thermo Fisher will be able to provide an end-to-end solution for its biopharma customers. Dr John Rontree, Senior Director of Marketing, Pharmaceuticals and Biopharmaceuticals, Thermo Fisher Scientific, discusses his company’s plans.
Quality by Design (QbD) is a method approach to developing a quality control system using predetermined objectives. It uses the foundations of risk management and science to ensure a repeatable process to manufacture high-quality products. In 2002, the FDA launched QbD as part of its innovation initiative. This paper outlines…
3M’s inventions have improved daily life for hundreds of millions of people all over the world since 1902. Silvia Perez, President and General Manager of the Drug Delivery Systems (DDS) Division of 3M, highlights some of her company’s recent innovations.
The pharma sector has changed over the past 21 years, with the growth of small and large molecule drug development and the greater requirement of technology. Christian Treitel, Director Strategy and Business Development, Robert Bosch Packaging Technology, gives his insight into the ever-evolving changes and challenges of the industry, and…
This supplement contains a collection of application notes and whitepapers from some of the leading suppliers to the pharmaceutical industry...
Tiffani Manolis, Director, Global Pharma Segment Marketing, Agilent Technologies, explains how her company’s solutions and portfolio have evolved with the pharma industry.
This In-Depth Focus looks at QbD and PAT for cutting biopharma attrition rates as well as continuous freeze-drying technology for biopharma products...
The pharmaceutical industry has seen a lot of change in the last 21 years. In 1996 the internet was relatively new and limited to computer access, mobile devices were bulky and expensive, and security concerns were primarily physical. Similarly, a lot has changed with regards to business, manufacturing and regulation,…
Mark Quick, Executive Vice-president, Corporate Development at Recipharm, explains how his company has set about becoming a best-in-class provider of contract development and manufacturing solutions to the pharmaceutical industry.
Catalent believes it is essential to share knowledge and experience to improve understanding of drug formulation and delivery challenges and contribute jointly to finding solutions. Will Downie, Senior Vice President, Global Sales and Marketing at Catalent, explains how his company makes a success of this strategy...
Andreas Weiler, Business Unit Head for Emerging Technologies, and Fatma Senkesen, Marketing Intelligence Associate Director, at Lonza, explain how their company has kept in step with industry developments.
